Related Experiment Video
Updated: May 27, 2026

High Frequency Ultrasound for the Analysis of Fetal and Placental Development In Vivo
Published on: November 8, 2018
[Prolonged pregnancy: when should surveillance be started and what should be the frequency?]
1Service de gynécologie-obstétrique, hôpital Nord, chemin des Bourrelys, 13015 Marseille, France. jeanbaptiste.haumonte@ap-hm.fr
Objective:
To determine when surveillance should be started in prolonged pregnancy and what would be the more appropriate frequency for it.
Study Design:
Systematic searches of Medline and the Cochrane Library were performed.
Results:
Fetal mortality diminishes from 37 weeks of gestation to a nadir of one death for 1000 births at 40(+0) weeks. It increases thereafter up to three deaths for 1000 births at 43(+0) weeks. Perinatal mortality rates show same pattern and is estimated to be of two and four to six deaths for 1000 births at 41(+0) and 43(+0) weeks, respectively. However, current available data does not allow for the determination of a gestational age cut-off associated with major increase of perinatal mortality and on which surveillance of prolonged pregnancy should be genuinely started. French epidemiological data from 2003 indicate that although 52.5% of pregnant women have reached 40(+0) weeks only 20,7% and 1% have reaches 41(+0) and 42(+0) weeks, respectively. Intrauterine fetal growth associated with prolonged pregnancy increases perinatal mortality. In most randomized trials having compared labour induction with expectant management, fetal surveillance was started at 41(+0) weeks.
Conclusion:
Due to the increased risk of perinatal mortality, it seems appropriate that fetal surveillance is started at 41(+0) weeks (expert opinion). This implies a rational organization of care to support surveillance of 20% of pregnant women. The frequency of this monitoring consisting of at least twice-weekly cadiotocography and ultrasound estimation of amniotic fluid (expert opinion).
Related Concept Videos
Longitudinal Research
Principles of Disease Surveillance
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Mitral Valve Prolapse III: Nursing Management
Ovarian Cycle

